Cogstate Limited (COGZF) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Healthcare Information Services 行业. 公司总部位于 Melbourne, VIC, 澳大利亚. 现任CEO为 Bradley John O'Connor.
COGZF 拥有 IPO日期为 2010-04-05, 147 名全职员工, 在 Other OTC, 市值为 $258.2M.
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
